Cardiol Therapeutics (CRDL) Goodwill & Intangibles (2020 - 2024)
Cardiol Therapeutics' (CRDL) quarterly Goodwill & Intangibles came in at $549219.5 in Q4 2024, up 255.45% YoY from $154515.4 in Q1 2024, and up 346.77% on a QoQ basis from $122931.0 in Q2 2024.
Cardiol Therapeutics (CRDL) Goodwill & Intangibles (2020 - 2024) Analysis & Trends
Cardiol Therapeutics (CRDL) has 5 years of Goodwill & Intangibles data on file, last reported at $549219.5 in Q4 2024.
- Quarterly Goodwill & Intangibles rose 255.45% year-over-year to $549219.5 in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $549219.5 (up 255.45% YoY) and the FY2024 annual result came in at $549219.5, up 255.45% from the prior year.
- Goodwill & Intangibles improved to $549219.5 in Q4 2024, from $122931.0 in the prior quarter.
- In the past five years, Goodwill & Intangibles ranged from a high of $588505.8 in Q4 2020 to a low of -$307800.1 in Q4 2021.
- A 5-year average of $231891.1 and a median of $217181.5 in 2022 frame the typical range for Goodwill & Intangibles.
- Annual changes were most pronounced in 2021 — Goodwill & Intangibles slumped 152.3% — and 2024, when it soared 255.45%.
- Tracing CRDL's Goodwill & Intangibles over 5 years: stood at $588505.8 in 2020, then slumped by 152.3% to -$307800.1 in 2021, then jumped by 170.56% to $217181.5 in 2022, then fell by 28.85% to $154515.4 in 2023, then soared by 255.45% to $549219.5 in 2024.
- The last three Goodwill & Intangibles figures came in at $549219.5 (Q4 2024), $122931.0 (Q2 2024), and $140442.7 (Q1 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | Cardiol Therapeutics | 215.50 Mn | 196.65 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 549,219.50 |
| Jun 30, 2024 | 122,931.05 |
| Mar 31, 2024 | 140,442.70 |
| Dec 31, 2023 | 154,515.42 |
| Sep 30, 2023 | 172,659.78 |
| Jun 30, 2023 | 188,033.80 |
| Mar 31, 2023 | 202,448.24 |
| Dec 31, 2022 | 217,181.50 |
| Sep 30, 2022 | 242,225.11 |
| Jun 30, 2022 | 264,341.62 |
| Mar 31, 2022 | 282,738.77 |
| Dec 31, 2021 | -307,800.12 |
| Sep 30, 2021 | 318,047.33 |
| Jun 30, 2021 | 342,875.66 |
| Dec 31, 2020 | 588,505.82 |